FDA Warns of Fatal Risks with Cephalon, Inc. Pain Drug

WASHINGTON, Sept 26 (Reuters) - U.S. drug regulators on Wednesday issued a public health advisory warning of the potential for a deadly overdose of a pain drug for cancer patients made by Cephalon Inc (CEPH.O: Quote, Profile, Research).

Back to news